{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:21:20Z","timestamp":1790709680269,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.clindermatol.2011.03.017","type":"journal-article","created":{"date-parts":[[2011,12,8]],"date-time":"2011-12-08T14:19:58Z","timestamp":1323353998000},"page":"108-113","source":"Crossref","is-referenced-by-count":86,"title":["Severity score indexes for blistering diseases"],"prefix":"10.1016","volume":"30","author":[{"given":"Benjamin S.","family":"Daniel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hertl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria P.","family":"Werth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00fcdiger","family":"Eming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9d\u00e9e F.","family":"Murrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2011.03.017_bb0005","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1365-2133.2008.08481.x","article-title":"The health impact of pemphigus vulgaris and pemphigus foliaceus assessed using the Medical Outcomes Study 36-item short form health survey questionnaire","volume":"158","author":"Tabolli","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.017_bb0010","first-page":"4","article-title":"Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) in pemphigus","volume":"17","author":"Pfutze","year":"2007","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.017_bb0015","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1001\/archdermatol.2007.14","article-title":"Treatment of pemphigus: the need for more evidence","volume":"144","author":"Martin","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.017_bb0020","first-page":"CD006263","article-title":"Interventions for pemphigus vulgaris and pemphigus foliaceus","author":"Martin","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clindermatol.2011.03.017_bb0025","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jaad.2008.01.012","article-title":"Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus","volume":"58","author":"Murrell","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.017_bb0030","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1038\/jid.2009.72","article-title":"Reliability and convergent validity of two outcome instruments for pemphigus","volume":"129","author":"Rosenbach","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.017_bb0035","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1046\/j.1365-4362.2003.01811.x","article-title":"A new grading system for oral pemphigus","volume":"42","author":"Saraswat","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.017_bb0040","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000187431","article-title":"Clinical and immunological follow-up of pemphigus patients on adjuvant treatment with immunoadsorption or rituximab","volume":"218","author":"Pfutze","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2011.03.017_bb0045","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1001\/archderm.143.2.192","article-title":"Clinical response of severe mechanobullous epidermolysis bullosa acquisita to combined treatment with immunoadsorption and rituximab (anti-CD20 monoclonal antibodies)","volume":"143","author":"Niedermeier","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.017_bb0050","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1365-4632.2005.02218.x","article-title":"Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases","volume":"44","author":"Mahajan","year":"2005","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.017_bb0055","first-page":"158","article-title":"Pemphigus Area and Activity Score (PAAS)\u2014a novel clinical scoring method for monitoring of pemphigus vulgaris patients","volume":"37","author":"Agarwal","year":"1998","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.017_bb0060","first-page":"239","article-title":"Correlation of pemphigus vulgaris antibody titers by indirect immunofluorescence with activity of disease based on pemphigus area and activity score (PAAS)","volume":"46","author":"Mortazavi","year":"2008","journal-title":"Acta Medica Iranica"},{"key":"10.1016\/j.clindermatol.2011.03.017_bb0065","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1007\/s00403-002-0367-2","article-title":"History of the establishment and revision of diagnostic criteria, severity index and therapeutic guidelines for pemphigus in Japan","volume":"295","author":"Ikeda","year":"2003","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.clindermatol.2011.03.017_bb0070","first-page":"251","article-title":"A nation-wide questionnaire investigation about severity and treatment of pemphigus (second report). Annual Report of the Intractable Skin Diseases Study Group","author":"Ogawa","year":"1995","journal-title":"Ministry Welfare Health Tokyo, Japan"},{"key":"10.1016\/j.clindermatol.2011.03.017_bb0075","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0190-9622(00)90213-5","article-title":"Patterns of remission in pemphigus vulgaris","volume":"42","author":"Herbst","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.017_bb0080","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa011592","article-title":"A comparison of oral and topical corticosteroids in patients with bullous pemphigoid","volume":"346","author":"Joly","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2011.03.017_bb0085","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1001\/archderm.1966.01600230074020","article-title":"Clinical significance of autoantibodies in pemphigus","volume":"93","author":"Chorzelski","year":"1966","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.017_bb0090","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1046\/j.1365-2133.2001.04132.x","article-title":"The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels","volume":"144","author":"Harman","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.017_bb0095","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2340\/00015555-0868","article-title":"Correlation of immunological profile with phenotype and disease outcome in pemphigus","volume":"90","author":"Herrero-Gonzalez","year":"2010","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2011.03.017_bb0100","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.4049\/jimmunol.159.4.2010","article-title":"Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins","volume":"159","author":"Ishii","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.clindermatol.2011.03.017_bb0105","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1600-0625.2010.01069.x","article-title":"Novel ELISA systems for antibodies to desmoglein 1 and 3: correlation of disease activity with serum autoantibody levels in individual pemphigus patients","volume":"19","author":"Schmidt","year":"2010","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.017_bb0110","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1001\/archderm.1980.01640270045011","article-title":"The correlation of disease activity and antibody titers in pemphigus","volume":"116","author":"Fitzpatrick","year":"1980","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.017_bb0115","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/0190-9622(91)70322-S","article-title":"A review of two controlled multicenter trials comparing 0.05% halobetasol propionate ointment to its vehicle in the treatment of chronic eczematous dermatoses","volume":"25","author":"Guzzo","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.017_bb0120","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/00003226-199209000-00015","article-title":"Improved detection of disease progression in ocular cicatricial pemphigoid","volume":"11","author":"Tauber","year":"1992","journal-title":"Cornea"},{"key":"10.1016\/j.clindermatol.2011.03.017_bb0125","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0161-6420(81)35069-6","article-title":"Ocular cicatricial pemphigoid","volume":"88","author":"Mondino","year":"1981","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2011.03.017_bb0130","first-page":"527","article-title":"Cicatricial pemphigoid","volume":"84","author":"Foster","year":"1986","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.clindermatol.2011.03.017_bb0135","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/archopht.122.2.179","article-title":"A new method for measuring progression in patients with ocular cicatricial pemphigoid","volume":"122","author":"Rowsey","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clindermatol.2011.03.017_bb0140","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4103\/0019-5154.53173","article-title":"Pemphigus: active or inactive?","volume":"54","author":"Vaishnani","year":"2009","journal-title":"Indian J Dermatol"}],"updated-by":[{"DOI":"10.1016\/j.clindermatol.2016.03.002","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000}}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X11000939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X11000939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T12:27:40Z","timestamp":1686486460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X11000939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0738081X11000939"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2011.03.017","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}